Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 6.8B | 6.8B | 6.7B | 6.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | 0 | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 50M | 50M | 49M | 50M |
| Other income expense | 22M | 19M | 24M | 26M |
| Pretax income | 783M | 1.1B | 952M | 912M |
| Tax provision | 153M | 221M | 185M | 174M |
| Net income | 630M | 853M | 767M | 738M |
| Basic EPS | 2.2 | 2.9 | 2.6 | 2.5 |
| Diluted EPS | 2.2 | 2.9 | 2.6 | 2.4 |
| Basic average shares | 286.6M | 289.3M | 292.6M | 295.5M |
| Diluted average shares | 290.8M | 294.2M | 297.5M | 299.9M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 630M | 853M | 767M | 738M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |